Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Therapeutic Targets for Alzheimer's Disease: Amyloid Vs. Non-Amyloid. Where Does Consensus Lie Today? An CTAD Task Force Report

8 Mar 2022

Abstract excerpt

There was consensus that both amyloid and tau pathologies should be targeted in Alzheimer's disease, as well as additional pathophysiological mechanisms such as neuroinflammation. The selection of one or both of these targets may depend upon a personalized approach that takes into account the genetic and acquired factors that cause AD in any given person as well as their stage of disease as reflected in a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Cholinesterase and Neurodegenerative Diseases
Share to Computational Drug Discovery Methods

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35542994
DOI: 10.14283/jpad.2022.29

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Therapeutic Targets for Alzheimer's Disease: Amyloid Vs. Non-Amyloid. Where Does Consensus Lie Today? An CTAD Task Force ReportPMID 35542994Read ↗

Perspective Insights into Disease Progression, Diagnostics, and Therapeutic Approaches in Alzheimer's Disease: A Judicious UpdateSemantic proximity Read ↗

New clues to Alzheimer's disease: unraveling the roles of amyloid and tau.Semantic proximity Read ↗

Recent Insights into Neurobiology of Alzheimer's Disease and Advanced Treatment Strategies.Semantic proximity Read ↗

Alzheimer’s disease pathogenesis and therapeutic interventionsSemantic proximity Read ↗

Therapeutic targets for Alzheimer's disease.Semantic proximity Read ↗

Tau therapeutics for Alzheimer's disease: the promise and the challenges.Semantic proximity Read ↗

Amyloid-beta in Alzheimer's disease: the horse or the cart? Pathogenic or protective?Semantic proximity Read ↗

Amyloid β-peptide and Alzheimer's disease.Semantic proximity Read ↗

Alzheimer's disease: molecular concepts and therapeutic targets.Semantic proximity Read ↗

Deciphering Alzheimer's disease: the amyloid precursor protein yields new clues.Semantic proximity Read ↗

The amyloid cascade and Alzheimer's disease therapeutics: theory versus observationSemantic proximity Read ↗

[Alzheimer's disease: a molecular mechanism, new hypotheses, and therapeutic strategies].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.